Clinical Trials List
Protocol NumberEFC11072
2011-10-01 - 2013-08-01
Phase II/III
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHENG-HAN WU Division of Rheumatology
- 吳柏樟 Division of Rheumatology
- KO-JEN LI Division of Rheumatology
- SONG-CHOU HSIEH Division of Rheumatology
- PING-NING HSU Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 張筱桾 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
1740 participants
